Поисковый запрос: (<.>S=ВЫСОКОДОЗНАЯ<.>) |
Общее количество найденных документов : 207
Показаны документы с 1 по 20
|
|
1.
| A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle // Bone Marrow Transplant., 2000. Vol. 25, N 5.-С.519-524
|
2.
| A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle // Bone Marrow Transplant., 2000. Vol. 25, N 5.-С.519-524
|
3.
| A randomized study of VAD therapy with either concurrent or maintenance interferon in patients with newly diagnosed multiple myeloma // Brit. J. Haematol., 1996. Vol. 94, N 4.-С.659-664
|
4.
| A review of 331 rabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan // Int. J. Clin. Oncol., 2007. Vol. 12, N 2.-С.137-145
|
5.
| A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma // Brit. J. Haematol., 2002. Vol. 116, N 1.-С.229-235
|
6.
| A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma // Brit. J. Haematol., 2002. Vol. 116, N 1.-С.229-235
|
7.
| Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients // Cancer, 1996. Vol. 78, N 6.-С.1293-1299
|
8.
| Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients // Cancer, 1996. Vol. 78, N 6.-С.1293-1299
|
9.
| Autologous bone marrow transplantation vs peripheral blood progenitor cells (PBPC) transplantation for poor risk breast cancer: Clinical, economic and quality of life assessment // Bone Marrow Transplant., 1995. Vol. 15, Suppl. n 2.-С.110
|
10.
| Autologous bone marrow transplantation vs peripheral blood progenitor cells (PBPC) transplantation for poor risk breast cancer: Clinical, economic and quality of life assessment // Bone Marrow Transplant., 1995. Vol. 15, Suppl. n 2.-С.110
|
11.
| Autologous stem cell transplantation in multiple myeloma performed in the Department of Hematology in Lublin // Acta haematol. pol., 2001. Vol. 32, прил. N 1.-С.161
|
12.
| Autologous stem cell transplantation in multiple myeloma performed in the Department of Hematology in Lublin // Acta haematol. pol., 2001. Vol. 32, прил. N 1.-С.161
|
13.
| CD34{+} selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma // Bone Marrow Transplant., 2000. Vol. 25, N 11.-С.1175-1184
|
14.
| CD34{+} selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma // Bone Marrow Transplant., 2000. Vol. 25, N 11.-С.1175-1184
|
15.
| CD34{+} selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma // Bone Marrow Transplant., 2000. Vol. 25, N 11.-С.1175-1184
|
16.
| Clonotypic CD20{+} an CD19{+} B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation // Brit. J. Haematol., 1999. Vol. 106, N 2.-С.545-552
|
17.
| Clonotypic CD20{+} an CD19{+} B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation // Brit. J. Haematol., 1999. Vol. 106, N 2.-С.545-552
|
18.
| Clonotypic CD20{+} an CD19{+} B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation // Brit. J. Haematol., 1999. Vol. 106, N 2.-С.545-552
|
19.
| Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: A pilot study // Anticancer Res., 2005. Vol. 25, N 4.-С.3047-3054
|
20.
| Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: A pilot study // Anticancer Res., 2005. Vol. 25, N 4.-С.3047-3054
|
&uf('+1W2226#',v2226), ?>
|
|